Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06615752
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-16
Brief Title:
Green Tea and Quercetin in Combination with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase III Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin with Docetaxel in Castration-resistant Prostate Cancer Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer ie metastatic castration-resistant prostate cancer mCRPC It will also learn about the safety of this combination
Researchers will compare green tea plus quercetin to a placebo a look-alike substance that contains no drug in combination with docetaxel to see if green tea and quercetin works to improve the therapeutic effect of docetaxel
Researchers will compare green tea plus quercetin to a placebo a look-alike substance that contains no drug in combination with docetaxel to see if green tea and quercetin works to improve the therapeutic effect of docetaxel
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None